Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

First Confirmed Case Of 2009 H1N1 Flu In Navajo County
Navajo County Public Health Services District officials announced today the first case of 2009 H1N1 in Navajo County. The Arizona Department of Health Services Lab confirmed that an 18 year old patient at Little Colorado Medical Center tested positive for the illness. The patient has subsequently been treated and released.

Simple Measures May Prevent Transmission Of Stomach Ulcer Bacteria
The stomach ulcer bacterium Helicobacter pylori is not transmitted through drinking water as previously thought, but rather through vomit and possibly faeces. This is shown in a thesis at the Sahlgrenska Academy, University of Gothenburg, Sweden. It is therefore possible to prevent the spread of the bacterium in developing countries through some fairly simple measures.
News of the day
Seattle Genetics Initiates Phase II Trial Of SGN-35 For Anaplastic Large Cell Lymphoma
Seattle Genetics, Inc. (NASDAQ:SGEN), announced that it has initiated a phase II clinical trial of SGN-35 for patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). SGN-35 is an antibody-drug conjugate (ADC) that utilizes Seattle Genetics" proprietary technology to empower antibodies by linking them to potent cell-killing drugs.
Endocrinology

AcroMetrix Announces The Release Of OptiQual(R) GBS Positive Control For Use With Diagnostic Assays That Detect Group B Streptococcus

AcroMetrix, a leading manufacturer of quality control standards and controls for clinical diagnostic and blood testing laboratories, announced the release of the first standardized quality control for molecular Group B Streptococcus (GBS) testing. The OptiQual GBS Positive Control is designed to help clinical laboratories comply with CLIA guidelines for qualitative molecular assays that detect Group B Streptococcus DNA, ensuring accuracy and precision throughout the testing procedure. Colonization of an expectant mother with Group B Streptococcus can pose an extreme threat to the newborn, potentially causing pneumonia, sepsis, or meningitis. In order to appropriately manage prevention of GBS transmission, obstetricians and labor and delivery nurses are beginning to utilize the more rapid and sensitive methods of PCR-based GBS detection. "As rapid, point-of-care molecular assays for Group B Streptococcus begin to replace the traditional culture-screening method, doctors and clinical laboratory technologists will want appropriate quality control materials to accurately monitor the performance of their assays," says Michael J. Eck, President and CEO of AcroMetrix. "Ultimately, the goal is for doctors to more efficiently administer antibiotic prophylaxis in order to prevent GBS transmission from a mother to her newborn. AcroMetrix is dedicated to helping doctors achieve this goal by providing quality control products such as the OptiQual GBS Positive Control." The OptiQual GBS Positive Control is unassayed and contains inactivated whole Group B Streptococcus bacteria, providing a safer method of monitoring the entire molecular testing procedure from extraction through amplification and detection. Convenient and ready to use, the OptiQual GBS Positive Control is stored at refrigerated temperatures. This product is for in vitro diagnostic use. OptiQual is a registered trademark of AcroMetrix. AcroMetrix


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009